Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaletra”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00046033
What this trial is testing

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 118
Post-approval studies (Phase 4)Ended earlyNCT00632970
What this trial is testing

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals

Who this might be right for
HIV Infections
George Washington University 6
Post-approval studies (Phase 4)Study completedNCT00752037
What this trial is testing

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

Who this might be right for
HIV Infections
Saint Michael's Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00318123
What this trial is testing

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 126
Not applicableStudy completedNCT00762320
What this trial is testing

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Who this might be right for
HIV Infections
Phoenix Children's Hospital 8
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Not applicableStudy completedNCT00102986
What this trial is testing

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Not applicableStudy completedNCT00179335
What this trial is testing

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

Who this might be right for
HIV Infections
Albert Einstein College of Medicine 45
Post-approval studies (Phase 4)Study completedNCT00438152
What this trial is testing

Lopinavir Capsules to Kaletra or Invirase Tablets

Who this might be right for
HIV Infections
Royal Free Hampstead NHS Trust 53
Post-approval studies (Phase 4)Study completedNCT01533272
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Not applicableWithdrawnNCT00023218
What this trial is testing

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT01083810
What this trial is testing

Evaluation of Kaletra Therapy Over the Long-term

Who this might be right for
Human Immunodeficiency Virus
Abbott 284
Testing effectiveness (Phase 2)Study completedNCT04276688
What this trial is testing

Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

Who this might be right for
Novel Coronavirus Infection
The University of Hong Kong 127
Post-approval studies (Phase 4)Ended earlyNCT01068873
What this trial is testing

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Who this might be right for
HIV Infections
Temple University 1
Large-scale testing (Phase 3)Study completedNCT00711009
What this trial is testing

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Who this might be right for
Human Immunodeficiency Virus Infection
Abbott 206
Early research (Phase 1)Ended earlyNCT00044837
What this trial is testing

Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Post-approval studies (Phase 4)Ended earlyNCT00661349
What this trial is testing

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 9
Early research (Phase 1)Study completedNCT02256826
What this trial is testing

Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 34
Testing effectiveness (Phase 2)Study completedNCT00196625
What this trial is testing

Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-infected Patients in Virological Failure.

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 100
Testing effectiveness (Phase 2)UnknownNCT03836833
What this trial is testing

Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation

Who this might be right for
HIV
Drugs for Neglected Diseases 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation